Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion

Walls, Alexandra C., Xiong, Xiaoli, Park, Young-Jun, Tortorici, M. Alejandra, Snijder, Joost, Quispe, Joel, Cameroni, Elisabetta, Gopal, Robin, Dai, Mian, Lanzavecchia, Antonio, Zambon, Maria, Rey, Félix A., Corti, Davide, Veesler, David·2019·Cell
DOI 10.1016/j.cell.2018.12.028

Cited by (587)

Items 501–587 of 587

  1. Self-derived peptides from the SARS-CoV-2 spike glycoprotein disrupting shaping and stability of the homotrimer unit
    Monikaben Padariya, Alison Daniels, Christine Tait‐Burkard, Ted R. Hupp, Umesh Kalathiya · 2022 · Biomedicine & Pharmacotherapy
  2. “É difícil temer aquilo que não podemos ver”: o trabalho representacional da Covid-19 e a pedagogia do medo entre vírus e animações
    João Paulo Ferreira, Cristiane Vilma de Melo · 2022 · Physis Revista de Saúde Coletiva
  3. Predictive Models of within- and between-Species SARS-CoV-2 Transmissibility
    Ricardo Soares, Cristina P. Vieira, Jorge Vieira · 2022 · Viruses
  4. Computational design of scFv anti-receptor binding domain of SARS-CoV-2 spike protein based on antibody S230 anti-SARS-CoV-1
    Ade Rizqi Ridwan Firdaus, Umi Baroroh, Taufik Ramdani Tohari, Ari Hardianto, Toto Subroto, Muhammad Yusuf · 2023 · Journal of Biomolecular Structure and Dynamics
  5. Uncloaking the viral glycocalyx: How do viruses exploit glycoimmune checkpoints?
    Anthony J. Domma, Lauren A. Henderson, Jeffery A. Nurdin, Jeremy P. Kamil · 2024 · Advances in virus research
  6. Diagnosis for COVID-19
    Ashish Tripathi, Anand Bhushan Pandey, Arun Kumar Singh, Arush Jain, Vaibhav Tyagi, Prem Chand Vashist · 2021 · Springer eBooks
  7. Recent SARS-CoV-2 Outlook and Implications in a COVID-19 Vaccination Era
    Teddy Stephen Ehianeta, Said Abdulrahman Salim Mzee, Adebisi Muslimat Kehinde, Oluwayemisi Ehianeta · 2021 · Infectious Microbes & Diseases
  8. Computational epitope mapping of class I fusion proteins using low complexity supervised learning methods
    Marion F. S. Fischer, James E. Crowe, Jens Meiler · 2022 · PLoS Computational Biology
  9. Molecular adaptive evolution of SARS-COV-2 spike protein in Saudi Arabia
    Islam Nour, Ibrahim O. Alenazi, Atif Hanif, Saleh Ahmed Eifan · 2021 · Saudi Journal of Biological Sciences
  10. Deciphering the Protein Motion of S1 Subunit in SARS-CoV-2 Spike Glycoprotein Through Integrated Computational Methods
    Hao Tian, Peng Tao · 2020 · arXiv (Cornell University)
  11. TMPRSS2 Protease Inhibitors May Prolong But Heparins Accelerate SARS-CoV-2 Clearance
    Shu Yuan, Sicong Jiang, Zhongwei Zhang, Zi-Lin Li, Changquan Wang, Ming Zhe Yuan, Yang‐Er Chen, Qi Tao, Ting Lan, Xiaoyan Tang et al. · 2020 · Preprints.org
  12. Review of COVID-19 Antibody Therapies
    Jiahui Chen, Kaifu Gao, Rui Wang, Duc Duy Nguyen, Guo‐Wei Wei · 2020 · arXiv (Cornell University)
  13. Comparison of N- and O-Glycosylation on Spike Glycoprotein 1 of SARS-CoV-1 and MERS-CoV
    Yuan Tian, John F. Cipollo · 2025 · Journal of Proteome Research
  14. Enhancement of viral infection by antibodies and consequences
    Corentin Morvan, Magloire Pandoua Nekoua, Cyril Debuysschere, Enagnon Kazali Alidjinou, Didier Hober · 2025 · Microbiology and Molecular Biology Reviews
  15. Placental infection by SARS-CoV-2: exploring alternative entry pathways
    Carolina Lumi Tanaka Dino, Bárbara Maria Cavalli, Carolline Konzen Klein, Felipe Paes Gomes da Silva, Nícolas Henrique Borges, Ana Catharina Joaquim, Thiago Rodrigues dos Santos, Natan de Araújo, Lucas Baena Carstens, Ana Clara Almeida et al. · 2025 · Tissue Barriers
  16. Heterologous saRNA prime – multivalent protein boost strategy induces broad and durable immunity against SARS-CoV-2 and MERS-CoV
    Dominik Renn, Justine S. McPartlan, Srinivas Banala, Fabian M. Kiessling, Poulami Talukder, Christian W. Mandl, Jörg Eppinger, Jasdave S. Chahal, Magnus Rueping · 2026 · Scientific Reports
  17. Resposta imune humoral na COVID-19
    Pablo Rafael Silveira Oliveira, Natália Machado Tavares · 2020 · EDUFBA eBooks
  18. Recent scientific research progress and challenges of COVID-19 pandemic: a global public health event
    Shalmali Hui · 2021 · Proceedings of the Indian National Science Academy
  19. Essentials of COVID-19 and treatment approaches
    Aditi Pandey, Shivam Yadav · 2022 · Elsevier eBooks
  20. Coronavirus Pandemics
    Claudia Ferreira, Marie-Françoise J. Doursout, Joselito S. Balingit · 2023 · Springer eBooks
  21. Heterogeneous Condensation on Simplified Viral Envelope Protein Structures
    Kawkab Ahasan, Han Hu, Pranav Shrotriya, Todd A. Kingston · 2025 · ACS Applied Materials & Interfaces
  22. Drug Targets for Corona Virus (COVID-19): A Systematic Review
    Jayakumar K · 2020 · Scholars International Journal of Biochemistry
  23. The Oral Cavity May be Vulnerable to SARS COV - 2 Entry Due to Certain Physiological Factors and Pathological Conditions
    Saranya Varadarajan, Thodur Madapusi Balaji, C.J. Venkatakrishnan, Raghunathan Jagannathan, S. Lakshmi Priya, Dr.V. Raj Prabhu, Dr. Caroline Francis, Swaminathan Rajendran, Dr. S. Devi · 2020 · Indian Journal of Research in Pharmacy and Biotechnology
  24. Scrutinizing Coronaviruses Using Publicly Available Bioinformatic Tools: The Viral Structural Proteins as a Case Study
    Sonia Beeckmans, Edilbert VAN DRIESSCHE · 2021 · Frontiers in Molecular Biosciences
  25. Natural Compounds Activities against SARS-CoV-2 Mpro through Bioinformatics Approaches for Development of Antivirus Candidates
    Taufik Muhammad Fakih · 2021 · Jurnal Kimia Sains dan Aplikasi
  26. Boosting the analysis of protein interfaces with multiple interface string alignments: Illustration on the spikes of coronaviruses
    S. Bereux, Bernard Delmas, Frédéric Cazals · 2021 · Proteins Structure Function and Bioinformatics
  27. Surface-enhanced Raman scattering of CoV-SARS-2 viral proteins in a strong coupling regime
    Konstantin E. Mochalov, Pavel S. Samokhvalov, Galina Nifontova, Tatiana Tsoi, Alyona V. Sukhanova, Igor R. Nabiev · 2021 · Journal of Physics Conference Series
  28. Use of simplified models for theoretical prediction of the interactions between available antibodies and the receptor-binding domain of SARS-CoV-2 spike protein
    Guillermo Antonio Huerta-Miranda, Wendy I. García-García, Abraham Marcelino Vidal Limón, Margarita Miranda‐Hernández · 2021 · Journal of Biomolecular Structure and Dynamics
  29. Immunogenicity and safety of adenovirus-based vector vaccines for COVID-19: a systematic review and meta-analysis
    Ayers Gilberth Ivano Kalaij, Valerie Josephine Dirjayanto, Syarif Maulana Yusuf, Erni Juwita Nelwan · 2021 · Medical Journal of Indonesia
  30. Antibodies against spike protein of SARS-CoV-2 variants in bovine whey IgG enriched fraction
    Satoshi Oshiro, Naeko Mizutani, Tatsuya Tada, Jun‐ichiro Sekiguchi, Masao Takahashi, Teruo Kirikae · 2022 · International Dairy Journal
  31. Monoclonal antibody and blood plasma ABO blood group based therapy against COVID-19
    Shimuye Kalayu Yirga, Jianda Hu, Minhui Lin · 2020
  32. SARS-CoV-2 Preimmune IgM Epitopes
    Velizar Stefanov Shivarov, Peter V. Petrov, Anastas Dimitrov Pashov · 2020
  33. Hypothesis of Potential Evolution of SARS-CoV-2 through Hybridization of SARS-CoV-1 with Saccharomyces cerevisiae and Mycobacterium avium naturally inside an immunocompromised Pangolin
    Shimaa M. Abdelgawad · 2020
  34. Synthetic protein antigens for COVID-19 diagnostics
    Catherine H. Schein, Corri B. Levine, Susan McLellan, Surendra S. Negi, Werner A. Braun, Stephen C. Dreskin, Elizabeth S. Anaya, Jurgen G. Schmidt · 2021 · medRxiv
  35. Free Energy Landscapes for RBD Opening in SARS-CoV-2 Spike Glycoprotein Simulations Suggest Key Interactions and a Potentially Druggable Allosteric Pocket
    Lucy Fallon, Kellon A. A. Belfon, Lauren E. Raguette, Yuzhang Wang, Christopher P. Corbo, Darya Stepanenko, Abbigayle E. Cuomo, José Guerra, Stephanie Budhan, Sarah Varghese et al. · 2020 · ChemRxiv
  36. An ultra-long heavy chain bovine antibody neutralizes SARS-CoV-2 and reacts broadly with sarbecoviruses.
    Theocharis Tsoleridis, Chengcheng Fan, Emily J. Park, Joshua D. Duncan, Parul Sharma, Sophie Wartnaby, Joseph G. Chappell, Anja Kipar, Eleanor G. Bentley, Adam Kirby et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  37. Corona Virus (SARS-COV-2) Induced Inflammatory Lung Disease a Review on the Role of Renin–Angiotensin System and the Angiotensin Converting Enzyme-2
    Sanjeev Arya, David Maskill, Avinash Kumar Sharma, Ankit Khanduri, Prashant Kumar, Dushyant Singh Gaur, Haider Abbas, Sheetal Verma, Vinita Singh · 2020 · American Journal of Internal Medicine
  38. Serology: A Precise Tool in Diagnosis and Epidemiology of COVID-19
    Bramhadev Pattnaik, Mahendra Pal Yadav, S. S. Patil, Pinaki Panigrahi · 2020 · ACTA SCIENTIFIC MICROBIOLOGY
  39. A Bioinformatics Protocol for Rational Design of Peptide Vaccines and the COVID-19 Rampage
    Ashesh Nandy, Subhash C. Basak, Smarajit Manna · 2020 · Archives of Proteomics and Bioinformatics
  40. Immunological Approaches and Different Strategies for Vaccine Development Against SARS-COV-2
    Muhammed Babakir‐Mina · 2020 · Kurdistan Journal of Applied Research
  41. Prevalence of IgG Antibodies to SARS-CoV-2 in Wuhan – Implications for the Longevity of Antibodies Against SARS-CoV-2
    Tao Liu, Sanyun Wu, Huangheng Tao, Guang Qiao Zeng, Fuling Zhou, Xinghuan Wang · 2020
  42. 重组SARS-COV-2穗蛋白的特异性N-糖基化表征
    永张, 万君赵, 永洪毛, 姚辉陈, 石寿王, y忠, 陶苏, 孟公, 丹杜, 小峰鲁 et al. · 2021
  43. Gene Influencing in COVID-19 Infection, Disease Severity and its Pharmacotherapy
    Sougata Sarkar, Shreyashi Dasgupta, Vartika Srivastava, Satyabrata Sahoo, Santanu Kumar Tripathi · 2021 · International Journal of Current Research and Review
  44. Peer Review #2 of "Bioinformatic prediction of immunodominant regions in spike protein for early diagnosis of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (v0.1)"
    2021 · PeerJ
  45. Altered N-/O-Glycosylation Sites On The Receptor-Binding Domain (RBD) in COVID-19 Are Related To Coronavirus Infection And Pathogenesis.
    Shiwei Wang, Fan Xiao, Lingling He, Junru Yang, Hongshan Wei · 2021 · Research Square
  46. Impact of the SARS-CoV-2 S-protein G476S mutation on the interaction with human ACE-2 receptor and neutralizing antibodies
    Alexander Kwarteng, Ebenezer Asiedu, Augustina Angelina Sylverken, Amma Aboagyewa Larbi, Peter Twumasi · 2021 · Research Square
  47. COVID-19 pandemic: The deadly respiratory disease of 21st century
    Shweta Jain, Pankaj Kumar Jain, Ramakant Yadav, Surendra Jain, Ankur Vaidya · 2021 · Current Research in Pharmaceutical Sciences
  48. Novel Corona Virus Disease 2019 (Review on nCOVID-19)
    Muhammad Mudassar Shahzad, Syed Hussain, Rahat Abdul Rehman, Zawar Hussain, Sana Bashir, Fatima Khalid, Tahir Rafique, Kalsoom Akhtar, Laraib Tahir, Majid Hussain et al. · 2020
  49. Challenges and Progress in Vaccine Development for COVID-19 Coronavirus (SARS-CoV-2): A Review
    Keshav S. Moharir, Sumit Arora, Subhash R. Yende, Govind K. Lohiya, Sapan Shah · 2021 · The Open COVID Journal
  50. Potential Molecular Players Against to SARS-CoV-2: A Glyco-Perspective
    B Tugrul, Erdal Balcan, Zübeyde Öztel · 2021 · Journal of Cell Biology and Histology
  51. A Focus on Severe Acute Respiratory Syndrome ( SARS ) Coronavirus ( SARS‐CoVs ) 1 and 2
    Rolando Cannalire, Enzo Tramontano, Vincenzo Summa · 2021 · Methods and principles in medicinal chemistry
  52. Peer Review #1 of "Bioinformatic prediction of immunodominant regions in spike protein for early diagnosis of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (v0.2)"
    2021 · PeerJ
  53. Structure and function analysis of a potent human neutralizing antibody CA521LALA against SARS-CoV-2
    Changlin Dou, Cheng‐Feng Qin, Lan Wang, Deyong Song, Yong‐Qiang Deng, Wenbo Wang, Chuangchuang Dong, Zhenfei Ning, Xiu Liu, Chuan Liu et al. · 2021 · Research Square
  54. Peer Review #1 of "Bioinformatic prediction of immunodominant regions in spike protein for early diagnosis of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (v0.1)"
    2021 · PeerJ
  55. Possible long-term downsides of antibodies caused by the COVID-19 vaccine
    Adnan Erol · 2021
  56. Alimentary System is Directly Attacked by SARS-COV-2 and might Further Prevent Immune Dysregulation Caused by COVID-19 (Preprint)
    Yunhan Jiang, Jing Zhou, Xiaoqi Ou, Wei Cheng, Yun Qin, Sai Chen · 2020
  57. Genetic landscape of SARS-CoV-2
    Xueming Zheng, Wen Zhang · 2020
  58. Alimentary System is Directly Attacked by SARS-COV-2 and Further Prevent Immune Dysregulation Caused by COVID-19
    Sai Chen, Jing Zhou, Xiaoqi Ou UG, Wei Cheng, Yun Qin, Yingqiang Guo, Yunhan Jiang · 2020
  59. The unique interactions and binding/unbinding process between SARS-CoV-2 and receptor ACE2
    Shenxin Liu, Bo Zhang, Yingchun Liu, Qi Wang · 2022 · Scientia Sinica Chimica
  60. Structural basis of Omicron immune evasion: A comparative computational study of Spike protein-Antibody interaction
    Darshan Contractor, Christoph Globisch, Shiv Swaroop, Alok K. Jain · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  61. Characterizing flexibility and mobility in the natural mutations of the SARS-CoV-2 spikes
    James Panayis, Navodya S. Römer, Dom Bellini, A. Katrine Wallis, Rudolf A. Römer · 2022 · Journal of Physics Conference Series
  62. Structure, genomic analysis, and pathogenesis of SARS-CoV-2
    Divya Gupta, Onkar Awadhiya, Saurabh Saigal, Ashok Kumar · 2022 · Elsevier eBooks
  63. Impact of the SARS-CoV-2 S-protein G476S mutation on the interaction with human ACE-2 receptor and neutralizing antibodies
    Alexander Kwarteng, Ebenezer Asiedu, Augustina Angelina Sylverken, Amma Aboagyewa Larbi, Peter Twumasi · 2021 · Research Square
  64. Atomic-level characterization of the conformational transition pathways in SARS-CoV-1 and SARS-CoV-2 spike proteins
    Dylan S. Ogden, Mahmoud Moradi · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  65. An alpaca-derived nanobody recognizes a unique conserved epitope and retains potent activity against the SARS-CoV-2 omicron variant
    N. Modhiran, S. Lauer, A. Amarilla, P. Hewins, Sara Lopes van den Broek, Y. Low, Nazia Thakur, Benjamin Liang, Guillermo Valenzuela Nieto, James Jung et al. · 2022 · bioRxiv
  66. Antibodies utilizing VL6-57 light chains target a convergent cryptic epitope on SARS-CoV-2 spike protein driving the genesis of Omicron variants
    Qihong Yan, Xijie Gao, Banghui Liu, Ruitian Hou, Ping He, Yong Ma, Yudi Zhang, Yanjun Zhang, Zimu Li, Qiuluan Chen et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  67. Modeling Methods
    Longbing Cao · 2023 · Data analytics
  68. Broadly neutralizing antibodies against emerging delta-coronaviruses
    Megi Rexhepaj, Young‐Jun Park, Lisa Perruzza, Daniel E. Asarnow, Matthew McCallum, Katja Culap, Christian Saliba, Giada Leoni, Alessio Balmelli, Courtney N. Yoshiyama et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  69. Integrating Computational Approaches from Non-synonymous Sequence Variations to Molecular Structure for Drug Repositioning Targeting the SARS-CoV-2 Spike Protein
    Leon S. C. Costa, Isabella Alvim Guedes, Haron Calegari Fanticelli, Marisa Nicolás, Laurent E. Dardenne · 2024 · Computer-aided drug discovery and design
  70. SARS-CoV-2 Delta Variant Spike Protein: Structure, Mechanism, and Docking Interaction with Antiviral Ligands from the Plants of the Phyllanthus Genus
    Ashokkumar Sibiya, Baskaralingam Vaseeharan, Palaniappan Ramasamy, Sundaresan Bhavaniramya · 2024 · Coronaviruses
  71. Rapid Discovery of Potent Neutralizing Antibodies against SARS-CoV-2 through Directed Evolution of SARS-CoV-1 Antibodies
    Inji Jung, Dinesh Kumar Sriramulu, Jeong Hyeon Yoon, Jisun Lee, Tae Woo Kim, Dae‐Hyuk Kweon, Sun‐Gu Lee, Sang Taek Jung · 2025 · Molecular Pharmaceutics
  72. Heterologous saRNA Prime – Multivalent Protein Boost Strategy Induces Broad and Durable Immunity Against SARS-CoV-2 and MERS-CoV
    Dominik Renn, Justine S. McPartlan, Srivinas Banala, Fabian M. Kiessling, Poulami Taldukder, Christian W. Mandl, Jasdave S. Chahal, Jörg Eppinger, Magnus Rueping · 2025 · Research Square
  73. Probing the Broad-Spectrum Virus-Neutralizing Epitopes Using the High-Density Oligomannose-Conjugates and Carbohydrate Microarrays
    Christian Toonstra, Lisa Y. Wu, Lai‐Xi Wang, Denong Wang · 2025 · Bioconjugate Chemistry
  74. Human coronavirus HKU1 neutralization by glycan receptor mimicry
    Ziqi Feng, Nurgun Kose, Fernando R. Moreira, Anne L. M. Kimpel, Jeffrey Copps, Naveenchandra Suryadevara, Daniel J. Jackson, James E. Gern, Ian A. Wilson, Sheng Li et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  75. Repurposing niclosamide for COVID-19: Synergistic strategies of nanotechnology and novel materials to enhance antiviral efficacy
    Haichuan Rong, Junyi Ren, Qifeng Wu, Haijun Zhu, Chenshuang Dong, Guiling Wang · 2025 · Microbial Pathogenesis
  76. Computational analyses of the G476S variant of SARS-CoV-2: A focus on the interaction with human ACE-2 and neutralizing antibodies
    Alexander Kwarteng, Ebenezer Asiedu, Augustina Angelina Sylverken · 2020 · Research Square
  77. Additional file 4 of Complete genome sequencing of SARS-CoV-2 strains: A pilot survey in Palestine reveals spike mutation H245N
    Amer Al‐Jawabreh, Suheir Ereqat, Kamal Dumaidi, Hanan Al-Jawabreh, Abedelmajeed Nasereddin · 2021 · Figshare
  78. Additional file 3 of Complete genome sequencing of SARS-CoV-2 strains: A pilot survey in Palestine reveals spike mutation H245N
    Amer Al‐Jawabreh, Suheir Ereqat, Kamal Dumaidi, Hanan Al-Jawabreh, Abedelmajeed Nasereddin · 2021 · Figshare
  79. Additional file 1 of Complete genome sequencing of SARS-CoV-2 strains: A pilot survey in Palestine reveals spike mutation H245N
    Amer Al‐Jawabreh, Suheir Ereqat, Kamal Dumaidi, Hanan Al-Jawabreh, Abedelmajeed Nasereddin · 2021 · Figshare
  80. Additional file 2 of Complete genome sequencing of SARS-CoV-2 strains: A pilot survey in Palestine reveals spike mutation H245N
    Amer Al‐Jawabreh, Suheir Ereqat, Kamal Dumaidi, Hanan Al-Jawabreh, Abedelmajeed Nasereddin · 2021 · Figshare
  81. Additional file 1 of Precision therapeutic targets for COVID-19
    Zachary A. Krumm, Grace M. Lloyd, Francis, Connor P., Lith H. Nasif, Mitchell, Duane A., Golde, Todd E., Benoit I. Giasson, Yuxing Xia · 2021 · Figshare
  82. A neutralizing human antibody induces movement of the HCoV-229E receptor binding domain
    Mera F. Liccione, Trevor Scobey, Heather M. Froggatt, Camryn Pajon, Boyd L. Yount, Qi Yin, Taylor N. Spence, Emmanuel B. Walter, Kevin O. Saunders, Robert J. Edwards et al. · 2025 · Communications Biology
  83. Etude structurale et fonctionnelle de la glycoprotéine des Rhabdovirus
    Laura Belot · 2019 · theses.fr (ABES)
  84. Caractérisation des activités antivirales des anticorps anti-VIH-1 et anti-SARS-CoV-2
    Jérémy Dufloo · 2021 · theses.fr (ABES)
  85. The S1 B -Targeting PEDV Neutralizing Antibody C62 Prematurely Activates S-trimer and Mimics Receptor Function
    Jianbo Liu, Sheng Wang, Zimu Li, Mengzhen Su, Zhichen Wang, Ying Li, Jiahui Zou, Xuerui Zhu, Heying Li, Yong Li Jiang et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  86. Distinct mechanisms of neutralization by antibodies targeting a conserved pneumovirus F epitope
    Sebastian Ols, Rodrigo Arcoverde Cerveira, Andrew J. Borst, Erick Bermúdez-Méndez, Florian A. Gegenfurtner, Elise Eray, Connor Weidle, Marcos C. Miranda, Zhitong Peng, Kenneth D. Carr et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  87. Receptor-induced activation of MERS-CoV spike revealed by time-course cryo-EM
    Yajie Wang, Xiyuan Pan, Yuxuan Jiang, Zhimin Liu, Yinong Qiu, Zhenguo Chen, Lei Sun · 2026 · PLoS Pathogens